
Founders and VCs did an unprecedented amount of creative financing last year.
Raising a priced VC round was really tough in 2023, as we all know. So what did thousands of founders do instead?
They raised an extension / bridge round using convertible notes or SAFEs.
Again, all of these convertible financings happened AFTER a company has already raised the primary round.
In 2020, $58M went into Series C companies on convertible notes. Just 3 years later, that number ballooned up to $874M.
With the messiness of seed-stage trends, I'm unsurprised that a lot of cash is moving to those companies through SAFEs or notes even after a priced round.
But Series B and C? That suggests a serious inability to raise primaries and represents a pretty large and uncertain bet by founders and investors on those middle growth scaleups.
But at least this is a little bit of the answer to "where will all the dry powder go?"
More data from Carta out every Thursday in our Data Minute newsletter! Subscribe for so many reasons, on of which being we're the only place to track SAFE and Convertible Note trends these days.
#cartadata #fundraising #founders #convertiblenotes #SAFEs
DISCLOSURE: This communication is on behalf of eShares, Inc. dba Carta, Inc. ("Carta"). This communication is for informational purposes only, and contains general information only. Carta is not, by means of this communication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services nor should it be used as a basis for any decision or action that may affect your business or interests. Before making any decision or taking any action that may affect your business or interests, you should consult a qualified professional advisor. This communication is not intended as a recommendation, offer or solicitation for the purchase or sale of any security. Carta does not assume any liability for reliance on the information provided herein. © 2026 Carta. All rights reserved. Reproduction prohibited.



